Last data update: Nov 04, 2024. (Total: 48056 publications since 2009)
Records 1-3 (of 3 Records) |
Query Trace: Choat J [original query] |
---|
Antimicrobial susceptibility of Francisella tularensis isolates in the United States, 2009-2018
Choat J , Young J , Petersen JM , Dietrich EA . Clin Infect Dis 2024 78 S4-s6 Francisella tularensis is the causative agent of tularemia. We tested the susceptibility of 278 F. tularensis isolates from the United States received during 2009-2018 to 8 antimicrobial drugs (ciprofloxacin, levofloxacin, doxycycline, tetracycline, gentamicin, streptomycin, chloramphenicol, and erythromycin). All isolates were susceptible to all tested drugs. |
Development and validation of a real-time PCR test to detect Bartonella quintana in clinical samples
Choat J , Yockey B , Sheldon SW , Pappert R , Petersen J , Dietrich EA . Diagn Microbiol Infect Dis 2023 106 (4) 116000 This study reports on the validation of a real-time polymerase chain reaction test targeting the vomp region of Bartonella quintana. The assay displayed 100% sensitivity and specificity for the 52 bloods and 159 cultures tested. Molecular diagnosis of Bartonella quintana can aid clinical treatment during acute infection. |
Borrelia miyamotoi infection in immunocompromised man, California, USA, 2021
Rubio LA , Kjemtrup AM , Marx GE , Cronan S , Kilonzo C , Saunders MEM , Choat JL , Dietrich EA , Liebman KA , Park SY . Emerg Infect Dis 2023 29 (5) 1011-1014 Infection with Borrelia miyamotoi in California, USA, has been suggested by serologic studies. We diagnosed B. miyamotoi infection in an immunocompromised man in California. Diagnosis was aided by plasma microbial cell-free DNA sequencing. We conclude that the infection was acquired in California. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Nov 04, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure